Lenalidomide Safe As Single Therapy For Elderly Leukemia Patients, Study Finds
Early-Stage HER2+ Breast Cancer Patients Are At Significant Risk Of Recurrence
Age Doesn’t Affect Survival After Bone Marrow Transplant
Lenalidomide Found Effective For Lymphoma In Phase II Trial
Intensive Chemo Equivalent To Transplant For MCL
Expanding Umbilical Cord Stem Cells Found Safe As Standard Transplant
Arzerra Promising For Heavily Pre-Treated CLL Patients
Dismissed Leukemia Drug Helps CLL, Clinical Trials Find
PDX Shows 27% Response In T-Cell Lymphoma In Study
Second-Generation CML Drugs Show Promise For Frontline
Gleevec To Prevent Recurrence Of Gastrointestinal Cancer
NCI Cooperative Group, Cancer Center Trials Listed
Trending Stories
- DOD cancer research programs face 57% funding cut in year-long continuing resolution
Pancreatic, lung, kidney cancer research programs eliminated - What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns” - Kennedy announces massive cuts, centralization at HHS—NCI and FDA hit
Also this week: Columbia yields, Makary and Bhattacharya confirmed, tariffs on pharmaceuticals, and more changes impacting oncology - In The Headlines: HHS shakeup threatens a legacy of medical breakthroughs
- Alec Kimmelman named director of Perlmutter Cancer Center, quickly replacing ousted Benjamin Neel
- Jonathan Friedberg tells us how he built a cancer center in an underserved area of New York State
